A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1

Summary

The purpose of this study is to learn about the effects of an investigational medicine, PGN-EDODM1, to see how safe and tolerable multiple administrations of PGN-EDODM1 are for people with myotonic dystrophy type 1 (DM1) compared to placebo.

Timeline

Start

2024-12-10

Primary completion

2027-03

Completion

2027-03

Drugs

Indications